|
Diabetes, Vol 43, Issue 3 384-388, Copyright © 1994 by American Diabetes Association
Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications
M Marre, P Bernadet, Y Gallois, F Savagner, TT Guyene, M Hallab, F Cambien, P Passa and F Alhenc-Gelas
Medical Department B, University Hospital, Angers, France.
Insulin-dependent diabetes mellitus (IDDM), cardiovascular morbidity, and
vital prognosis are linked to diabetic nephropathy, which is probably
determined by renal hemodynamic abnormalities and by a genetic
predisposition. Angiotensin I converting enzyme (ACE) regulates systemic
and renal circulations through angiotensin II formation and kinins
metabolism. Plasma and cellular ACE levels are genetically determined; an
insertion/deletion polymorphism of the ACE gene is strongly associated with
ACE levels, subjects homozygote for insertion (genotype II) having the
lowest plasma values. We studied the relationship between the ACE gene
polymorphism or plasma levels and microcirculatory disorders of IDDM
through two independent studies: one involved 57 subjects with or without
diabetic retinopathy, and the other compared 62 IDDM subjects with diabetic
nephropathy to 62 diabetic control subjects with the same characteristics
(including retinopathy severity) but with normal kidney function. The ACE
genotype distribution was not different in diabetic subjects with or
without retinopathy and in a healthy population. Conversely, an imbalance
of ACE genotype distribution, with a low proportion of II subjects, was
observed in IDDM subjects with diabetic nephropathy compared with their
control subjects (P = 0.006). Plasma ACE levels were mildly elevated in all
diabetic groups, independently of retinopathy, but they were higher in
subjects with nephropathy than in those without nephropathy (P = 0.0022).
The II genotype of ACE gene is a marker for reduced risk for diabetic
nephropathy.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Qian, E. Feldman, S. Pennathur, M. Kretzler, and F. C. Brosius III
From Fibrosis to Sclerosis: Mechanisms of Glomerulosclerosis in Diabetic Nephropathy
Diabetes,
June 1, 2008;
57(6):
1439 - 1445.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tarnow, P.-H. Groop, S. Hadjadj, G. Kazeem, F. Cambien, M. Marre, C. Forsblom, H.-H. Parving, D. Tregouet, A. Thevard, et al.
European rational approach for the genetics of diabetic complications EURAGEDIC: patient populations and strategy
Nephrol. Dial. Transplant.,
August 17, 2007;
(2007)
gfm501v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hadjadj, L. Tarnow, C. Forsblom, G. Kazeem, M. Marre, P.-H. Groop, H.-H. Parving, F. Cambien, D. A. Tregouet, I. G. Gut, et al.
Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy: Case-Control, Haplotype, and Family-Based Study in Three European Populations
J. Am. Soc. Nephrol.,
April 1, 2007;
18(4):
1284 - 1291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Stone, M. E. Craig, A. K. Chan, J. W. Lee, C. F. Verge, and K. C. Donaghue
Natural History and Risk Factors for Microalbuminuria in Adolescents With Type 1 Diabetes: A longitudinal study.
Diabetes Care,
September 1, 2006;
29(9):
2072 - 2077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P.K. Ng, G. Placha, S. Choo, K.-s. Chia, J. H. Warram, and A. S. Krolewski
A Disease Haplotype for Advanced Nephropathy in Type 2 Diabetes at the ACE Locus
Diabetes,
September 1, 2006;
55(9):
2660 - 2663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Weekers, B. Bouhanick, S. Hadjadj, Y. Gallois, R. Roussel, F. Pean, A. Ankotche, G. Chatellier, F. Alhenc-Gelas, P. J. Lefebvre, et al.
Modulation of the Renal Response to ACE Inhibition by ACE Insertion/Deletion Polymorphism During Hyperglycemia in Normotensive, Normoalbuminuric Type 1 Diabetic Patients
Diabetes,
October 1, 2005;
54(10):
2961 - 2967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Boright, A. D. Paterson, L. Mirea, S. B. Bull, A. Mowjoodi, S. W. Scherer, B. Zinman, and and the DCCT/EDIC Research Group
Genetic Variation at the ACE Gene Is Associated With Persistent Microalbuminuria and Severe Nephropathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study
Diabetes,
April 1, 2005;
54(4):
1238 - 1244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kakoki, N. Takahashi, J. C. Jennette, and O. Smithies
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
PNAS,
September 7, 2004;
101(36):
13302 - 13305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Narita, S Goto, N Saito, J Song, K Omori, D Kondo, M Sakatsume, and F Gejyo
Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism
J. Med. Genet.,
December 1, 2003;
40(12):
e130 - 130.
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Takahashi, J. R. Hagaman, H.-S. Kim, and O. Smithies
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
Endocrinology,
June 1, 2003;
144(6):
2184 - 2190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Andersen, L. Tarnow, F. Cambien, P. Rossing, T. R. Juhl, J. Deinum, and H.-H. Parving
Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy: Interaction with ACE insertion/deletion genotype?
Diabetes Care,
May 1, 2003;
26(5):
1501 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Taniwaki, E. Ishimura, T. Kawagishi, N. Matsumoto, M. Hosoi, M. Emoto, T. Shoji, S. Shoji, T. Nakatani, M. Inaba, et al.
Intrarenal Hemodynamic Changes After Captopril Test in Patients With Type 2 Diabetes: A duplex Doppler sonography study
Diabetes Care,
January 1, 2003;
26(1):
132 - 137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. X. Liao and A. C. Roy
Lack of association between polymorphisms in the testis-specific angiotensin converting enzyme gene and male infertility in an Asian population
Mol. Hum. Reprod.,
March 1, 2002;
8(3):
299 - 303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P Garg and G. L Bakris
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Vascular Medicine,
February 1, 2002;
7(1):
35 - 43.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Solini, M. Dalla Vestra, A. Saller, R. Nosadini, G. Crepaldi, and P. Fioretto
The Angiotensin-Converting Enzyme DD Genotype Is Associated With Glomerulopathy Lesions in Type 2 Diabetes
Diabetes,
January 1, 2002;
51(1):
251 - 255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Huang, Y. Gallois, N. Bouby, P. Bruneval, D. Heudes, M.-F. Belair, J. H. Krege, P. Meneton, M. Marre, O. Smithies, et al.
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
PNAS,
October 25, 2001;
(2001)
231476798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Taniwaki, E. Ishimura, N. Matsumoto, M. Emoto, M. Inaba, and Y. Nishizawa
Relations Between ACE Gene and ecNOS Gene Polymorphisms and Resistive Index in Type 2 Diabetic Patients With Nephropathy
Diabetes Care,
September 1, 2001;
24(9):
1653 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Harrap and S. Petrou
Utility of genetic approaches to common cardiovascular diseases
Am J Physiol Heart Circ Physiol,
July 1, 2001;
281(1):
H1 - H6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sanada, Y. Higashi, K. Nakagawa, S. Sasaki, I. Kodama, M. Tsuda, N. Nagai, and K. Ohama
Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women
J. Am. Coll. Cardiol.,
May 1, 2001;
37(6):
1529 - 1535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. HADJADJ, R. BELLOUM, B. BOUHANICK, Y. GALLOIS, G. GUILLOTEAU, G. CHATELLIER, F. ALHENC-GELAS, and M. MARRE
Prognostic Value of Angiotensin-I Converting Enzyme I/D Polymorphism for Nephropathy in Type 1 Diabetes Mellitus: A Prospective Study
J. Am. Soc. Nephrol.,
March 1, 2001;
12(3):
541 - 549.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. P. Rossi, S. Taddei, A. Virdis, L. Ghiadoni, G. Albertin, S. Favilla, I. Sudano, A. C. Pessina, and A. Salvetti
Exclusion of the ACE D/I Gene Polymorphism as a Determinant of Endothelial Dysfunction
Hypertension,
February 1, 2001;
37(2):
293 - 300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Crisan and J. Carr
Angiotensin I-Converting Enzyme: Genotype and Disease Associations
J. Mol. Diagn.,
August 1, 2000;
2(3):
105 - 115.
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Koch, A. Kastrati, J. Mehilli, C. Bottiger, N. von Beckerath, and A. Schomig
Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene Is Not Associated With Restenosis After Coronary Stent Placement
Circulation,
July 11, 2000;
102(2):
197 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Hsieh, S.-R. Lin, T.-J. Hsieh, C.-H. Hsu, H.-C. Chen, S.-J. Shin, and J.-H. Tsai
Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan
Nephrol. Dial. Transplant.,
July 1, 2000;
15(7):
1008 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Higaki, S. Baba, T. Katsuya, N. Sato, K. Ishikawa, T. Mannami, J. Ogata, and T. Ogihara
Deletion Allele of Angiotensin-Converting Enzyme Gene Increases Risk of Essential Hypertension in Japanese Men : The Suita Study
Circulation,
May 2, 2000;
101(17):
2060 - 2065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. OGIHARA, T. KATSUYA, and J. HIGAKI
Genetic Analysis of Essential Hypertension in Japanese Populations
Ann. N.Y. Acad. Sci.,
May 1, 2000;
902(1):
8 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lovestone
Diabetes and dementia
Neurology,
December 1, 1999;
53(9):
1907 - 1907.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. NANNIPIERI, G. PENNO, L. PUCCI, H. COLHOUN, C. MOTTI, A. BERTACCA, L. RIZZO, L. DE GIORGIO, G. ZERBINI, R. MANGILI, et al.
Pronatriodilatin Gene Polymorphisms, Microvascular Permeability, and Diabetic Nephropathy in Type 1 Diabetes Mellitus
J. Am. Soc. Nephrol.,
July 1, 1999;
10(7):
1530 - 1541.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
O. Costerousse, J. Allegrini, J.-P. Clozel, J. Ménard, and F. Alhenc-Gelas
Angiotensin I-Converting Enzyme Inhibition but Not Angiotensin II Suppression Alters Angiotensin I-Converting Enzyme Gene Expression in Vessels and Epithelia
J. Pharmacol. Exp. Ther.,
March 1, 1998;
284(3):
1180 - 1187.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. S. Yudkin, C. Andres, V. Mohamed-Ali, M. Gould, A. Panahloo, A. P. Haines, S. Humphries, and P. Talmud
The Angiotensin-Converting Enzyme Gene and the Angiotensin II Type I Receptor Gene as Candidate Genes for Microalbuminuria : A Study in Nondiabetic and Non–Insulin-Dependent Diabetic Subjects
Arterioscler. Thromb. Vasc. Biol.,
October 1, 1997;
17(10):
2188 - 2191.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Marre, G. Chatellier, and F. Alhenc-Gelas
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy
BMJ,
December 14, 1996;
313(7071):
1554c - 1555.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Hosoi, Y. Nishizawa, K. Kogawa, T. Kawagishi, T. Konishi, K. Maekawa, M. Emoto, S. Fukumoto, A. Shioi, T. Shoji, et al.
Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Carotid Arterial Wall Thickness in Non–Insulin-Dependent Diabetic Patients
Circulation,
August 15, 1996;
94(4):
704 - 707.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Doria, T. Onuma, G. Gearin, M. B. S. Freire, J. H. Warram, and A. S. Krolewski
Angiotensinogen Polymorphism M235T, Hypertension, and Nephropathy in Insulin-Dependent Diabetes
Hypertension,
May 1, 1996;
27(5):
1134 - 1139.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M.-L. Lachurie, M. Azizi, T.-T. Guyene, F. Alhenc-Gelas, and J. Menard
Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosterone System or Blood Pressure in Normotensive Subjects
Circulation,
June 15, 1995;
91(12):
2933 - 2942.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Breckenridge
Recent Advances: Clinical pharmacology and therapeutics
BMJ,
February 11, 1995;
310(6976):
377 - 380.
[Full Text]
|
 |
|

|
 |

|
 |
 
J K Powrie, G F Watts, J N Ingham, N A Taub, P J Talmud, and K M Shaw
Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes
BMJ,
December 17, 1994;
309(6969):
1608 - 1612.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Huang, Y. Gallois, N. Bouby, P. Bruneval, D. Heudes, M.-F. Belair, J. H. Krege, P. Meneton, M. Marre, O. Smithies, et al.
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
PNAS,
November 6, 2001;
98(23):
13330 - 13334.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 by the American Diabetes Association.
|
|
| |
|